CTSC and central nervous system cancer: In subsequent experiments, we not only found that abnormally high expression of CTSC was associated with significantly shorter survival time of patients with glioma, but showed that it could also be used as an independent risk factor and a valuable prognostic parameter for patients with glioma based on bioinformatics methods.